Skip to main content

Market Overview

44 Stocks Moving In Tuesday's Mid-Day Session

Share:

Gainers

  • Viking Therapeutics, Inc. (NASDAQ: VKTX) climbed 87.8 percent to $19.51 after announcing top-line results from Phase 2 study of VK2809. The study achieved primary endpoint.
  • Bridgford Foods Corporation (NASDAQ: BRID) gained 25.2 percent to $17.15.
  • Navidea Biopharmaceuticals Inc (NYSE: NAVB) shares gained 20 percent to $0.2165 after the company reported acceptance into the National Institutes of Health Commercialization Accelerator Program.
  • Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) shares rose 19.2 percent to $3.385. Adial Pharmaceuticals successfully passed the patent opposition period in Europe for AD04 in alcohol use disorder.
  • Radcom Ltd. (NASDAQ: RDCM) climbed 17.8 percent to $14.425.
  • BioHiTech Global, Inc. (NASDAQ: BHTG) gained 17.1 percent to $3.6292 after the company disclosed that it has received local permit approval to build HEBioT resource recovery facility in Rensselaer New York.
  • ChemoCentryx, Inc. (NASDAQ: CCXI) rose 15.4 percent to $12.10. Vifor Pharma Group raised equity stake in ChemoCentryx from 6.6% to 21.2%.
  • Tilray, Inc. (NASDAQ: TLRY) climbed 14 percent to $136.979 after the company received US approval to import a medical cannabis study drug for a clinical trial at the UC San Diego.
  • Oasmia Pharmaceutical AB (NASDAQ: OASM) gained 14 percent to $2.96.
  • Nexeo Solutions Inc (NASDAQ: NXEO) shares rose 13.3 percent to $11.34. Univar Inc (NYSE: UNVR) announced plans to acquire Nexeo in a cash and stock transaction valued at $11.65 per share.
  • Surgery Partners, Inc. (NASDAQ: SGRY) climbed 12.2 percent to $16.50.
  • Cronos Group Inc. (NASDAQ: CRON) gained 11.3 percent to $11.33.
  • Zealand Pharma A/S (NASDAQ: ZEAL) gained 10.5 percent to $18.66 after the company achieved primary and key secondary endpoints in Phase 3 trial with sasiglucagon for severe hypoglycemia.
  • Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) climbed 10 percent to $4.575.
  • California Resources Corporation (NYSE: CRC) rose 9.6 percent to $40.33.
  • Century Aluminum Company (NASDAQ: CENX) gained 9.5 percent to $12.90.
  • Akcea Therapeutics, Inc. (NASDAQ: AKCA) climbed 8.8 percent to $27.04. Needham initiated coverage on Akcea Therapeutics with a Buy rating.
  • Mersana Therapeutics, Inc. (NASDAQ: MRSN) rose 7.9 percent to $12.02.
  • Maiden Holdings, Ltd. (NASDAQ: MHLD) surged 7.6 percent to $2.85.
  • Fate Therapeutics, Inc. (NASDAQ: FATE) gained 6.4 percent to $11.78 after the company announced a strategic collaboration with ONO Pharmaceutical to develop off-the-shelf, iPSC-derived CAR-T cell cancer immunotherapies.
  • Avon Products, Inc. (NYSE: AVP) rose 6.1 percent to $2.20 following reports Natura and other parties recently approached the company regarding a takeover.
  • Nutanix, Inc. (NASDAQ: NTNX) rose 5.8 percent to $49.12 after declining 11.56 percent on Monday.

Check out these big penny stock gainers and losers

Losers

  • Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) fell 13.8 percent to $196.85.
  • SAExploration Holdings, Inc. (NASDAQ: SAEX) shares dropped 12.8 percent to $7.06.
  • Apogee Enterprises, Inc. (NASDAQ: APOG) tumbled 12.7 percent to $42.0919 after the company missed Q2 earnings estimated and cut FY19 guidance.
  • China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) dropped 11.2 percent to $9.9444 after reporting 1H results.
  • Blink Charging Co. (NASDAQ: BLNK) shares fell 10.2 percent to $2.38.
  • Unity Biotechnology, Inc. (NASDAQ: UBX) shares dipped 10.1 percent to $20.65.
  • Tandem Diabetes Care, Inc. (NASDAQ: TNDM) fell 9.9 percent to $36.19.
  • Twin Disc, Incorporated (NASDAQ: TWIN) shares dipped 9.8 percent to $23.42 after reporting a $30 million common stock offering.
  • Workiva Inc. (NYSE: WK) declined 9.1 percent to $34.42. Morgan Stanley downgraded Workiva from Equal-Weight to Underweight.
  • MYnd Analytics, Inc. (NASDAQ: MYND) shares dropped 8.6 percent to $1.92.
  • Primerica, Inc. (NYSE: PRI) shares tumbled 8.4 percent to $116.20. Citigroup downgraded Primerica from Neutral to Sell.
  • PLx Pharma Inc. (NASDAQ: PLXP) shares fell 8.3 percent to $4.6750.
  • Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) dipped 8.2 percent to $5.2725.
  • Altimmune, Inc. (NASDAQ: ALT) shares dropped 7.8 percent to $4.51.
  • General Mills, Inc. (NYSE: GIS) shares fell 7.6 percent to $44.12. General Mills reported upbeat earnings for its first quarter, while sales missed views.
  • athenahealth, Inc. (NASDAQ: ATHN) fell 6.4 percent to $133.9595 after Elliott Management reportedly backed away from its $160 per share bid for the company.
  • Hooker Furniture Corporation (NASDAQ: HOFT) fell 6.2 percent to $37.60. Sidoti & Co. downgraded Hooker Furniture from Buy to Neutral.
  • Playa Hotels & Resorts N.V. (NASDAQ: PLYA) dipped 5.1 percent to $9.10. Nomura downgraded Playa Hotels & Resorts from Buy to Neutral.
  • Presidio Inc (NASDAQ: PSDO) fell 5 percent to $15.57 after announcing a secondary offering of 3 million shares of common stock.
  • FedEx Corporation (NYSE: FDX) fell 5 percent to $243.36. FedEx reported weaker-than-expected earnings for its forst quarter, while sales exceeded estimates. The company raised its FY19 earnings outlook and reaffirmed FY19 sales growth of 9 percent.
  • argenx SE - ADR (NASDAQ: ARGX) shares fell 4.1 percent to $90.00 after reporting a proposed $300 million offering of American Depositary Shares.
  • BorgWarner Inc. (NYSE: BWA) shares fell 3.8 percent to $42.49 after the company lowered its full-year forecast.
 

Related Articles (AKCA + ADIL)

View Comments and Join the Discussion!

Posted-In: Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com